Showing results 1 to 1 of 1
Issue Date | Title | Journal Title |
---|---|---|
2023 | Associations of tissue tumor mutational burden and mutational status with clinical outcomes in KEYNOTE-042: pembrolizumab versus chemotherapy for advanced PD-L1-positive NSCLC | ANNALS OF ONCOLOGY |